---
title: "600216.SH (600216.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600216.SH/news.md"
symbol: "600216.SH"
name: "600216.SH"
parent: "https://longbridge.com/en/quote/600216.SH.md"
datetime: "2026-05-21T01:33:28.208Z"
locales:
  - [en](https://longbridge.com/en/quote/600216.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600216.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600216.SH/news.md)
---

# 600216.SH (600216.SH) — Related News

### [Zhejiang Medicine released its first-quarter performance, with a net profit attributable to the parent company of 287 million yuan, a year-on-year decrease of 29.84%](https://longbridge.com/en/news/283827513.md)
*2026-04-23T12:03:57.000Z*
> Zhejiang Medicine released its performance for the first quarter of 2026, with revenue of 2.191 billion yuan, a year-on-

### [Zhejiang Medicine released its 2025 annual performance, with a net profit attributable to the parent company of 873 million yuan, a year-on-year decrease of 24.74%](https://longbridge.com/en/news/282348542.md)
*2026-04-10T12:59:04.000Z*
> Zhejiang Medicine released its 2025 annual report, reporting revenue of 8.881 billion yuan, a year-on-year decrease of 5

### [Zhejiang: Plans to accelerate the construction of the Zhejiang Medical Biological Information Database and explore the path of assetization of biomedical data](https://longbridge.com/en/news/282291353.md)
*2026-04-10T05:09:38.000Z*
> Zhejiang Province plans to accelerate the construction of a medical biological information database, aiming to release t

### [NPC undergoes a "major overhaul," with the vice president casting three abstention votes](https://longbridge.com/en/news/279592060.md)
*2026-03-18T11:45:00.000Z*
> On March 16, Nanjing Pharmaceutical held an extraordinary board meeting to carry out a major management overhaul. Direct

### [Shanghai Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final Dividend](https://longbridge.com/en/news/279579926.md)
*2026-03-18T10:45:00.000Z*
> Shanghai Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final Dividend

### [Pacific Securities: Prices of Vitamin A and Vitamin E have surged significantly, benefiting leading domestic companies](https://longbridge.com/en/news/279522433.md)
*2026-03-18T02:42:04.000Z*
> Pacific Securities released a research report indicating that the geopolitical conflict in the Middle East has led to a